These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23796067)

  • 1. Pharmacokinetics of caspofungin increased dosage in a patient on rifampin-containing anti-tubercular treatment.
    Calcagno A; Baietto L; Pagani N; Bertucci R; Rostagno R; D'Avolio A; Di Perri G; De Rosa FG
    Scand J Infect Dis; 2013 Nov; 45(11):882-4. PubMed ID: 23796067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction.
    van der Elst KC; Brüggemann RJ; Rodgers MG; Alffenaar JW
    Transpl Infect Dis; 2012 Aug; 14(4):440-3. PubMed ID: 22316392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC; Veringa A; Zijlstra JG; Beishuizen A; Klont R; Brummelhuis-Visser P; Uges DR; Touw DJ; Kosterink JG; van der Werf TS; Alffenaar JC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for interactions between caspofungin and nelfinavir or rifampin.
    Stone JA; Migoya EM; Hickey L; Winchell GA; Deutsch PJ; Ghosh K; Freeman A; Bi S; Desai R; Dilzer SC; Lasseter KC; Kraft WK; Greenberg H; Waldman SA
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4306-14. PubMed ID: 15504857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of caspofungin in ICU patients.
    Muilwijk EW; Schouten JA; van Leeuwen HJ; van Zanten AR; de Lange DW; Colbers A; Verweij PE; Burger DM; Pickkers P; Brüggemann RJ
    J Antimicrob Chemother; 2014 Dec; 69(12):3294-9. PubMed ID: 25139840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.
    Spriet I; Meersseman W; Annaert P; de Hoon J; Willems L
    Eur J Clin Pharmacol; 2011 Jul; 67(7):753-5. PubMed ID: 21638033
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants.
    Migoya EM; Mistry GC; Stone JA; Comisar W; Sun P; Norcross A; Bi S; Winchell GA; Ghosh K; Uemera N; Deutsch PJ; Wagner JA
    J Clin Pharmacol; 2011 Feb; 51(2):202-11. PubMed ID: 20679501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats.
    Leshinsky J; McLachlan A; Foster DJR; Norris R; Barrs VR
    PLoS One; 2017; 12(6):e0178783. PubMed ID: 28575121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiology-based pharmacokinetics of caspofungin for adults and paediatrics.
    Stader F; Wuerthwein G; Groll AH; Vehreschild JJ; Cornely OA; Hempel G
    Pharm Res; 2015 Jun; 32(6):2029-37. PubMed ID: 25522788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis.
    Castagnola E; Cappelli B; Faraci M; Fallani S; Cassetta MI; Novelli A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3775. PubMed ID: 17646422
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.
    Sáez-Llorens X; Macias M; Maiya P; Pineros J; Jafri HS; Chatterjee A; Ruiz G; Raghavan J; Bradshaw SK; Kartsonis NA; Sun P; Strohmaier KM; Fallon M; Bi S; Stone JA; Chow JW
    Antimicrob Agents Chemother; 2009 Mar; 53(3):869-75. PubMed ID: 19075070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of a transjugular intrahepatic portosystemic shunt on the pharmacokinetics of caspofungin in a critically ill patient.
    Spriet I; Meyfroidt G; Maleux G; Verslype C; Willems L
    Pharmacology; 2012; 90(5-6):247-50. PubMed ID: 23007631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
    Betts RF; Nucci M; Talwar D; Gareca M; Queiroz-Telles F; Bedimo RJ; Herbrecht R; Ruiz-Palacios G; Young JA; Baddley JW; Strohmaier KM; Tucker KA; Taylor AF; Kartsonis NA;
    Clin Infect Dis; 2009 Jun; 48(12):1676-84. PubMed ID: 19419331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of therapeutic concentrations of micafungin administered 5 days/week in a leukemic adolescent with invasive candidiasis.
    Castagnola E; Cangemi G; Barco S; Bandettini R; Dallorso S; Virga F; Dufour C
    Clin Microbiol Infect; 2014 Nov; 20(11):O975-6. PubMed ID: 24621154
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.
    Kawada M; Fukuoka N; Kondo M; Okazaki K; Kusaka T; Kawada K; Itoh S
    Pediatr Infect Dis J; 2009 Sep; 28(9):840-2. PubMed ID: 19636279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia.
    Undre NA; Stevenson P; Freire A; Arrieta A
    Pediatr Infect Dis J; 2012 Jun; 31(6):630-2. PubMed ID: 22301478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin.
    Bell SG
    Neonatal Netw; 2011; 30(5):329-33. PubMed ID: 21846628
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects.
    Undre NA; Stevenson P; Wilbraham D
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):237-44. PubMed ID: 24472403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.